Remission status in persistent depressive disorder following acute treatment with psychotherapy plus medication or medication alone: A 2-year naturalistic follow-up.
Sep 2026· Journal of Affective Disorders· Vol 415, pp.
122506
· 1 citation· 54 references
Medicine
TL;DR
Similar to the acute phase outcomes, no group differences emerged over the 2-year follow-up, suggesting no long-term benefit of a 12-week CBASP treatment with ADM over other PDD treatments.
Abstract
Objective
Long-term benefits of acute-phase treatments for persistent depressive disorder (PDD) are unclear. Treatment guidelines disagree on the efficacy of cognitive behavioral analysis system of psychotherapy (CBASP). We examined whether acute CBASP protected against recurrence in PDD patients over two years of naturalistic follow-up.
Methods
An observational study evaluated major depressive episode (MDE) recurrences in patients completing the Research Evaluating the Value of Augmenting Medication with Psychotherapy (REVAMP) trial. Enrollees 18-75 years had PDD: current chronic MDE, recurrent MDEs with incomplete recovery, or double depression. All received open-label antidepressant medication (ADM) for 12 weeks. Non-remitters, continuing on ADM, were randomized (2:2:1) to 12 weeks of 1) CBASP, 2) brief supportive therapy (BSP), or 3) ADM alone (MEDS). Patients completing this 12-week randomized phase were offered two-year follow-up. Blinded raters assessed the primary outcome, remission status, using the Longitudinal Interval Follow-up Evaluation and Hamilton Depression Rating Scale at 3-month intervals. Analyses evaluated group differences and non-specific predictors of remission status.
Results
Of 323 participants entering follow-up, 203 (62.8%) met current MDE criteria during follow-up, without between-group differences: BSP: 83 (65.3%), CBASP: 85 (60.2%), MEDS: 35 (63.6%), Chi-square = 0.75; p = 0.69. Remission after acute treatment, lack of comorbid anxiety disorder, and female gender were significantly associated with lower recurrence risk.
Conclusion
Similar to the acute phase outcomes, no group differences emerged over the 2-year follow-up, suggesting no long-term benefit of a 12-week CBASP treatment with ADM over other PDD treatments. Findings underscore the difficulty of PDD treatment and the importance of acute treatment remission.
TRIAL REGISTRATION
ClinicalTrials.gov identifier: NCT00057551.
It was found that lower baseline depression severity and higher self-efficacy predicted a better overall treatment outcome for all patients, and antidepressant medication and environmental quality of life predicted treatment outcome for patients receiving hypnotherapy.
Real-world data indicate that more than half of patients with depression had no observed ADT, highlighting the need for individualized strategies and adherence to clinical guidelines.
Yi-Yan Liu, B. De Los Santos, Michael Kim et al.· Journal of Affective Disorde...· 0 citations
Background and Objectives: Cognitive-behavioural therapy (CBT) for obsessive–compulsive disorder (OCD) has primarily been evaluated in short-term, high-intensity treatment protocols. However, remission trajectories during low-intensity CBT (LiCBT) delivered in routine clinical practice remain insufficiently characteris...
K. Mukai, Naomi Matsuura, Y. Hosoi et al.· Medicina· 0 citations
The translation of evidence-based psychological treatments into accessible, real-world care remains a central challenge in global mental health implementation. Although approximately 3.4% of Chinese adults meet criteria for Major Depressive Disorder (MDD), only around 12% receive any form of treatment. Developing brief...
Nai-Hong Xu, Dong-Rong Zhao, Hao-Ke Li et al.· Cognitive Therapy and Resear...· 0 citations
Bipolar disorder is a chronic psychiatric condition characterized by recurrent mood episodes and significant functional impairment. Although pharmacotherapy remains the primary treatment, relapse rates remain high, highlighting the need for effective adjunctive interventions. This study aimed to synthesize evidence on...
A. C. Phelps, Hendsun Hendsun, Ernawati Ernawati· Journal Of Medicine & Health· 0 citations
Le non-response among TRD patients was associated with depression later onset, prior ECT, absence of diabetes, and occupational inactivity, and Pharmacological treatment alone may be insufficient to improve LE, underscoring the need to integrate psychosocial and behavioral interventions.
M. Walaszek, W. Cubała, K. Pastuszak et al.· Journal of Psychiatric Resea...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.